ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 570

Signalling Pathways Identified in Salivary Glands from Primary Sjögren’s Syndrome Patients Reveal Enhanced Adipose Tissue Development, As Demonstrated By Microarray Analysis, Real-Time PCR and Immunohistochemistry

Lara A Aqrawi1, Janicke C Liaaen Jensen1, Gunnvor Øijordsbakken2, Ann-Kristin Ruus3, Ståle Nygård4,5, Marit Holden6, Roland Jonsson7,8, Hilde Kanli Galtung9 and Kathrine Skarstein10,11, 1Department of Oral Surgery and Oral Medicine, University of Oslo, Oslo, Norway, 2Department of Clinical Medicine, University of Bergen, Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway, 3Department of Oral Biology, University of Oslo, Oslo, Norway, 4Department of Informatics, University of Oslo, Oslo, Norway, 5Bioinformatics core facility, Institute for Cancer research, Oslo University Hospital, Oslo, Norway, 6Norwegian Computing Center, Oslo, Oslo, Norway, 7Broegelmann Research laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway, 8Department of Rheumatology, Haukeland University Hospital, Bergen, Bergen, Norway, 9Department of Oral Biology, University of Oslo, Oslo, Pakistan, 10Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway, 11Department of Pathology, Haukeland University Hospital, Bergen, Bergen, Norway

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: adipose tissue, interleukins (IL) and salivary gland, Sjogren's syndrome

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: Sjögren's Syndrome Poster I: Translational Research

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: : A characteristic feature of Sjögren’s syndrome (SS) is the destruction of salivary and lacrimal glands mediated by mononuclear cell infiltration. Adipocytes can also occupy a large portion of the salivary gland (SG) tissue area, although little is known about their significance in SS. We have previously investigated adipose tissue infiltration in SG biopsies from SS patients and non-SS sicca controls. Our findings indicated distinct incidence of adipose tissue replacement in SS patients, where adipocytes were detected in IL6 rich regions. We now aimed to examine the development of adipocytes in the SG microenvironment, and delineate their possible involvement in immune reactions.

Methods: A microarray analysis was performed on SG from 6 SS patients and 6 non-SS controls, where the expression levels of genes involved in adipose tissue development were assessed. Real-time PCR was carried out on SG from 14 SS patients and 15 non-SS controls to account for interleukin (IL)-6, IL10 and IL17 mRNA levels. Immunohistochemical staining of frozen SG tissue using IL17 was also conducted.

Results: Upregulated signalling pathways identified in SG of SS patients show prominent adipose tissue development and mitochondrial fatty acid beta-oxidation, including the genes ARID5B, OXCT1, BDH1, SOX8, HMGCS2, FTO, ECHS1, PCCA, ACADL and ACADVL. Genes involved in interferon production and signalling were also detected (IRF1, IRF9, IRF7), in addition to IL6, IL10, and IL17 (Figure 1, Table 1). Higher mRNA levels of IL6, IL17 and IL10 were also observed in the SG of SS patients compared to controls. Moreover, IL17+ cells were observed mostly interstitially in the SG and around adipocytes, also within the focal infiltrates.

Conclusion: Adipocyte development seems to be more prominent in the SG of SS patients at the site of inflammation, where adipose tissue replacement is also evident. Detection of IL17 positive adipocytes in the target organ suggests their involvement in immune reactions.


Disclosure: L. A. Aqrawi, None; J. C. Liaaen Jensen, None; G. Øijordsbakken, None; A. K. Ruus, None; S. Nygård, None; M. Holden, None; R. Jonsson, None; H. K. Galtung, None; K. Skarstein, None.

To cite this abstract in AMA style:

Aqrawi LA, Liaaen Jensen JC, Øijordsbakken G, Ruus AK, Nygård S, Holden M, Jonsson R, Galtung HK, Skarstein K. Signalling Pathways Identified in Salivary Glands from Primary Sjögren’s Syndrome Patients Reveal Enhanced Adipose Tissue Development, As Demonstrated By Microarray Analysis, Real-Time PCR and Immunohistochemistry [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/signalling-pathways-identified-in-salivary-glands-from-primary-sjogrens-syndrome-patients-reveal-enhanced-adipose-tissue-development-as-demonstrated-by-microarray-analysis-real-time-pcr-and/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/signalling-pathways-identified-in-salivary-glands-from-primary-sjogrens-syndrome-patients-reveal-enhanced-adipose-tissue-development-as-demonstrated-by-microarray-analysis-real-time-pcr-and/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology